AI assistant
COGNITION THERAPEUTICS INC — Director's Dealing 2021
Oct 8, 2021
34027_dirs_2021-10-07_9848f2a0-a14c-4078-8f7d-c36651e8615d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COGNITION THERAPEUTICS INC (CGTX)
CIK: 0001455365
Period of Report: 2021-10-07
Reporting Person: Ricciardi Lisa (Director, CEO & President)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.07 | 2029-09-29 | Common Stock (20095) | Direct | |
| Stock Option (right to buy) | $1.07 | 2030-02-27 | Common Stock (7729) | Direct | |
| Stock Option (right to buy) | $1.2 | 2030-06-01 | Common Stock (896177) | Direct | |
| Stock Option (right to buy) | $1.2 | 2030-03-23 | Common Stock (41737) | Direct |
Footnotes
F1: The options vest in four (4) equal annual installments beginning on the first anniversary of the option's grant date. The option was granted on September 29, 2019.
F2: The options vest in four (4) equal annual installments beginning on the first anniversary of the option's grant date. The option was granted on February 27, 2020.
F3: 25% of the shares underlying the option vest on the first anniversary of the option's grant date and the remaining 75% vest in equal monthly installments for the thirty-six (36) months thereafter. The option was granted on June 1, 2020.
F4: The option is fully vested.